Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

NCT02342444 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

606

Enrollment

OTHER

Sponsor class

Conditions

Trauma
Surgery
Deep Vein Thrombosis (DVT)
Thromboembolic Events

Interventions

DRUG: Enoxaparin Sodium Injection 30 mg BID
DRUG: Enoxaparin Sodium Injection 40 mg QD

Sponsor

Oregon Health and Science University